An Exploratory Study Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar I and II Patients From Valproic Acid to Depakote ER.
Phase of Trial: Phase IV
Latest Information Update: 27 Jan 2009
At a glance
- Drugs Valproate semisodium (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Jan 2009 Actual end date (Sep 2006) added as reported by ClinicalTrials.gov.
- 27 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.